This is a Validated Antibody Database (VAD) review about rat Nfatc1, based on 58 published articles (read how Labome selects the articles), using Nfatc1 antibody in all methods. It is aimed to help Labome visitors find the most suited Nfatc1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (7A6)
  • western blot knockout validation; mouse; fig 2
  • immunocytochemistry; mouse; fig 1
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in western blot knockout validation on mouse samples (fig 2) and in immunocytochemistry on mouse samples (fig 1). Front Immunol (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (7A6)
  • western blot knockout validation; mouse; loading ...; fig 7c
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in western blot knockout validation on mouse samples (fig 7c). Mol Cell Biol (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (7A6)
  • immunohistochemistry - paraffin section; mouse; fig 8d
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in immunohistochemistry - paraffin section on mouse samples (fig 8d). BMC Cancer (2022) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:1000; loading ...; fig s4b
Santa Cruz Biotechnology Nfatc1 antibody (Santacruz, 7294) was used in western blot on mouse samples at 1:1000 (fig s4b). J Immunother Cancer (2021) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; fig 6c
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples (fig 6c). Int J Mol Sci (2021) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 6b
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, SC-7294) was used in western blot on mouse samples (fig 6b). Int J Mol Sci (2021) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 7a
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples (fig 7a). Cancers (Basel) (2021) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 2d
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples (fig 2d). Cell Death Dis (2020) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:1000; loading ...; fig 2d
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples at 1:1000 (fig 2d). Mol Cells (2020) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology Nfatc1 antibody (Santa, sc-7294) was used in immunohistochemistry - paraffin section on human samples (fig 1c) and in western blot on human samples (fig 1c). Biol Res (2019) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 4c
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in immunocytochemistry on mouse samples at 1:100 (fig 4c). Transl Oncol (2019) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 2d
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples (fig 2d). Bone (2018) ncbi
mouse monoclonal (7A6)
  • western blot; rat; 1:500; loading ...; fig 4c
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, 7A6) was used in western blot on rat samples at 1:500 (fig 4c). Sci Rep (2017) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:500; loading ...; fig 4p
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples at 1:500 (fig 4p). Nat Commun (2017) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:600; fig 4a
In order to investigate the role of TRPC6 in the development of pulmonary fibrosis, Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples at 1:600 (fig 4a). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
mouse monoclonal (7A6)
  • western blot knockout validation; mouse; fig 2
  • immunocytochemistry; mouse; fig 1
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in western blot knockout validation on mouse samples (fig 2) and in immunocytochemistry on mouse samples (fig 1). Front Immunol (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 4b
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples (fig 4b). Int J Mol Sci (2016) ncbi
mouse monoclonal (H-10)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-17834) was used in western blot on human samples at 1:1000 (fig 4). Mol Med Rep (2016) ncbi
mouse monoclonal (7A6)
  • western blot; human; 1:200; fig 2
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on human samples at 1:200 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 1f
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples (fig 1f). Cell Death Dis (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 2b
In order to use knockout mice to determine the role of cereblon in T cells, Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in western blot on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (7A6)
  • chromatin immunoprecipitation; mouse; fig 7d
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in chromatin immunoprecipitation on mouse samples (fig 7d). Nat Commun (2016) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry; mouse; 1:100; fig 4
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Eur J Med Chem (2016) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; human; 1:50; loading ...; fig 3a
  • western blot; human; 1:200; loading ...; fig 3b
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in immunocytochemistry on human samples at 1:50 (fig 3a) and in western blot on human samples at 1:200 (fig 3b). J Mol Med (Berl) (2016) ncbi
mouse monoclonal (7A6)
  • chromatin immunoprecipitation; mouse; fig 2
  • western blot; mouse; 1:1000; fig s4
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in chromatin immunoprecipitation on mouse samples (fig 2) and in western blot on mouse samples at 1:1000 (fig s4). Nat Commun (2016) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry - frozen section; mouse; fig 5
In order to compare valve phenotypes of Cx37, Cx43, and Cx47 knockout mice by NFATc1 and connexin expression in normal developing venous valves, segregated Foxc2, and connexin-specific differences, Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in immunohistochemistry - frozen section on mouse samples (fig 5). Dev Biol (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; fig 7
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples (fig 7). Skelet Muscle (2016) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2
In order to characterize human cardiac valve development by endocardial-to-mesenchymal transformation and mesenchymal cell colonization, Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2). Development (2016) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; rat; 1:200; fig 6
  • immunocytochemistry; human; 1:200; fig s9
In order to study beta-cell proliferation due to DYRK1A and GSK3B inhibition, Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in immunocytochemistry on rat samples at 1:200 (fig 6) and in immunocytochemistry on human samples at 1:200 (fig s9). Nat Commun (2015) ncbi
mouse monoclonal (7A6)
  • western blot knockout validation; mouse; loading ...; fig 7c
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in western blot knockout validation on mouse samples (fig 7c). Mol Cell Biol (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:200; loading ...; fig 3c
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, 7A6) was used in western blot on mouse samples at 1:200 (fig 3c). Cell Death Differ (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; fig 2
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; mouse; fig 3
  • western blot; mouse; fig 3
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in immunocytochemistry on mouse samples (fig 3) and in western blot on mouse samples (fig 3). EMBO Mol Med (2015) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; human; 1:100
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in immunocytochemistry on human samples at 1:100. Cancer Lett (2015) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 2a
  • western blot; Salmonella enterica
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on mouse samples (fig 2a), in western blot on Salmonella enterica samples and in immunohistochemistry - paraffin section on human samples (fig 1a). Cell Death Dis (2015) ncbi
mouse monoclonal (7A6)
  • western blot; mouse
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples . J Biol Chem (2014) ncbi
mouse monoclonal (7A6)
  • western blot; mouse
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples . Exp Cell Res (2014) ncbi
mouse monoclonal (7A6)
  • chromatin immunoprecipitation; mouse
  • western blot; mouse; 1:1000
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in chromatin immunoprecipitation on mouse samples and in western blot on mouse samples at 1:1000. Nat Med (2014) ncbi
mouse monoclonal (7A6)
  • western blot; mouse
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz Biotechnology, sc-7294) was used in western blot on mouse samples . Molecules (2014) ncbi
mouse monoclonal (7A6)
  • western blot; human; fig 7f
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in western blot on human samples (fig 7f). PLoS ONE (2014) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; mouse; 1:200
In order to study the mechanism by which Cav1.2 modulates the function of hair follicle stem cells, Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in immunocytochemistry on mouse samples at 1:200. Genes Dev (2013) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry - paraffin section; human; 4 ug/ml
Santa Cruz Biotechnology Nfatc1 antibody (Santa Cruz, sc-7294) was used in immunohistochemistry - paraffin section on human samples at 4 ug/ml. Arthritis Res Ther (2012) ncbi
Invitrogen
mouse monoclonal (7A6)
  • immunocytochemistry; human; loading ...
Invitrogen Nfatc1 antibody (Thermofisher, MA3-024) was used in immunocytochemistry on human samples . BMC Cancer (2021) ncbi
mouse monoclonal (7A6)
  • immunocytochemistry; human; loading ...; fig 4e
  • western blot; human; loading ...; fig 4g
  • immunocytochemistry; mouse; loading ...; fig 4a
  • western blot; mouse; loading ...; fig 4c
Invitrogen Nfatc1 antibody (ThermoFisher, 7A6) was used in immunocytochemistry on human samples (fig 4e), in western blot on human samples (fig 4g), in immunocytochemistry on mouse samples (fig 4a) and in western blot on mouse samples (fig 4c). Bone Res (2021) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry; mouse; 1:100; loading ...
Invitrogen Nfatc1 antibody (Invitrogen, MA3-024) was used in immunohistochemistry on mouse samples at 1:100. J Cardiovasc Dev Dis (2021) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig 5a
In order to report the physiological role of sarcolipin upregulation in muscle myopathy, Invitrogen Nfatc1 antibody (Pierce Antibodies, MA3-024) was used in western blot on mouse samples (fig 5a). PLoS ONE (2017) ncbi
mouse monoclonal (7A6)
  • chromatin immunoprecipitation; mouse
  • western blot; mouse; fig 5d
In order to clarify the roles of SIRT1 in adipose tissues, Invitrogen Nfatc1 antibody (Thermo Fisher, MA3-024) was used in chromatin immunoprecipitation on mouse samples and in western blot on mouse samples (fig 5d). EMBO Rep (2017) ncbi
mouse monoclonal (7A6)
  • western blot; human; loading ...; fig 1a
In order to find DYRK1A increases NFATc1/alphaA protein levels and subsequent transcriptional activity, Invitrogen Nfatc1 antibody (Pierce, MA3-024) was used in western blot on human samples (fig 1a). PLoS ONE (2017) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; loading ...; fig s6b
In order to discuss the role of NFAT in type II diabetes, Invitrogen Nfatc1 antibody (Thermo, MA3-024) was used in western blot on mouse samples (fig s6b). PLoS Genet (2016) ncbi
mouse monoclonal (7A6)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 4
  • western blot; mouse; 1:1000; fig 4
In order to study the role of GDF11 in bone remodeling, Invitrogen Nfatc1 antibody (ThermoFisher, MA3-024) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4) and in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:2000; fig s6
In order to study slow-twitch type 1 muscle fibers and diaphragm assessment in mice overexpressing phospholamban, Invitrogen Nfatc1 antibody (Pierce Antibodies, 7A6) was used in western blot on mouse samples at 1:2000 (fig s6). Brain Behav (2016) ncbi
mouse monoclonal (7A6)
  • chromatin immunoprecipitation; mouse; fig 4
In order to identify novel components for regulation called NFAT and TFII-I binding elements in the calbindin-D28k promoter in response to serum deprivation, Invitrogen Nfatc1 antibody (Pierce, MA3-024) was used in chromatin immunoprecipitation on mouse samples (fig 4). Biochem Biophys Res Commun (2015) ncbi
mouse monoclonal (7A6)
  • western blot; mouse
In order to describe mechanisms of p38 activation that converge on NFATc1 and result in opposing effects on T cell immunity, Invitrogen Nfatc1 antibody (Thermo, MA3-024) was used in western blot on mouse samples . J Exp Med (2014) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 2c
Abcam Nfatc1 antibody (Abcam, ab25916) was used in immunohistochemistry on mouse samples (fig 2c). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7a
Abcam Nfatc1 antibody (Abcam, ab25916) was used in western blot on mouse samples at 1:1000 (fig 7a). Exp Ther Med (2017) ncbi
mouse monoclonal (7A6)
  • western blot; human; fig 6
Abcam Nfatc1 antibody (Abcam, ab2796) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
BioLegend
mouse monoclonal (7A6)
  • flow cytometry; mouse; 1:100; fig 4c
BioLegend Nfatc1 antibody (Biolegend, 649603) was used in flow cytometry on mouse samples at 1:100 (fig 4c). Nat Commun (2019) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (7A6)
  • immunocytochemistry; mouse; 1:50; fig 5d
Developmental Studies Hybridoma Bank Nfatc1 antibody (Biolegend, 7A6) was used in immunocytochemistry on mouse samples at 1:50 (fig 5d). J Exp Med (2017) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; fig 6c
Developmental Studies Hybridoma Bank Nfatc1 antibody (Santa Cruz Biotechnology, 7A6) was used in western blot on mouse samples (fig 6c). J Exp Med (2015) ncbi
mouse monoclonal (7A6)
  • western blot; mouse; 1:1000; loading ...
In order to measure NFAT isoforms in neural precursor cells, Developmental Studies Hybridoma Bank Nfatc1 antibody (Enzo Life, 7A6) was used in western blot on mouse samples at 1:1000. Glia (2015) ncbi
Articles Reviewed
  1. Kleinberger I, Sanders E, Staes K, Van Troys M, Hirano S, Hochepied T, et al. Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms. BMC Cancer. 2022;22:451 pubmed publisher
  2. Schanz O, Cornez I, Yajnanarayana S, David F, Peer S, Gruber T, et al. Tumor rejection in Cblb -/- mice depends on IL-9 and Th9 cells. J Immunother Cancer. 2021;9: pubmed publisher
  3. Huang J, Hu M, Niu H, Wang J, Si Y, Cheng S, et al. Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels. BMC Cancer. 2021;21:750 pubmed publisher
  4. Polavaram N, Dutta S, Islam R, Bag A, Roy S, Poitz D, et al. Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases. Bone Res. 2021;9:24 pubmed publisher
  5. Watahiki A, Hoshikawa S, Chiba M, Egusa H, Fukumoto S, Inuzuka H. Deficiency of Lipin2 Results in Enhanced NF-κB Signaling and Osteoclast Formation in RAW-D Murine Macrophages. Int J Mol Sci. 2021;22: pubmed publisher
  6. Moore K, Fulmer D, Guo L, Koren N, Glover J, Moore R, et al. PDGFRα: Expression and Function during Mitral Valve Morphogenesis. J Cardiovasc Dev Dis. 2021;8: pubmed publisher
  7. Varshney R, Ranjit R, Chiao Y, Kinter M, Ahn B. Myocardial Hypertrophy and Compensatory Increase in Systolic Function in a Mouse Model of Oxidative Stress. Int J Mol Sci. 2021;22: pubmed publisher
  8. Feng Y, Liu S, Zha R, Sun X, Li K, ROBLING A, et al. Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms. Cancers (Basel). 2021;13: pubmed publisher
  9. Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways. Aging (Albany NY). 2020;12:21706-21729 pubmed publisher
  10. Du T, Yan Z, Zhu S, Chen G, Wang L, Ye Z, et al. QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism. Cell Death Dis. 2020;11:330 pubmed publisher
  11. Kim K, Kim J, Kim I, Seong S, Kim N. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway. Mol Cells. 2020;43:34-47 pubmed publisher
  12. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  13. Li W, Yu X, Zhu C, Wang Z, Zhao Z, Li Y, et al. Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways. Biol Res. 2019;52:10 pubmed publisher
  14. Tiedemann K, Sadvakassova G, Mikolajewicz N, Juhas M, Sabirova Z, Tabariès S, et al. Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis. Transl Oncol. 2019;12:462-474 pubmed publisher
  15. Fujita S, Mukai T, Mito T, Kodama S, Nagasu A, Kittaka M, et al. Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis. Bone. 2018;106:156-166 pubmed publisher
  16. Honjoh C, Chihara K, Yoshiki H, Yamauchi S, Takeuchi K, Kato Y, et al. Association of C-Type Lectin Mincle with FcεRIβγ Subunits Leads to Functional Activation of RBL-2H3 Cells through Syk. Sci Rep. 2017;7:46064 pubmed publisher
  17. Li M, Shi X, Chen F, Hao F. Daphnetin inhibits inflammation in the NZB/W F1 systemic lupus erythematosus murine model via inhibition of NF-?B activity. Exp Ther Med. 2017;13:455-460 pubmed publisher
  18. Fajardo V, Gamu D, Mitchell A, Bloemberg D, Bombardier E, Chambers P, et al. Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice. PLoS ONE. 2017;12:e0173708 pubmed publisher
  19. Hui X, Zhang M, Gu P, Li K, Gao Y, Wu D, et al. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO Rep. 2017;18:645-657 pubmed publisher
  20. Liu H, Wang K, Chen S, Sun Q, Zhang Y, Chen L, et al. NFATc1 phosphorylation by DYRK1A increases its protein stability. PLoS ONE. 2017;12:e0172985 pubmed publisher
  21. Wu M, Chen W, Lu Y, Zhu G, Hao L, Li Y. Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway. Nat Commun. 2017;8:13700 pubmed publisher
  22. von Moltke J, O Leary C, Barrett N, Kanaoka Y, Austen K, Locksley R. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med. 2017;214:27-37 pubmed publisher
  23. Keller M, Paul P, Rabaglia M, Stapleton D, Schueler K, Broman A, et al. The Transcription Factor Nfatc2 Regulates β-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human Islets. PLoS Genet. 2016;12:e1006466 pubmed publisher
  24. Hofmann K, Fiedler S, Vierkotten S, Weber J, Klee S, Jia J, et al. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis. Biochim Biophys Acta Mol Basis Dis. 2017;1863:560-568 pubmed publisher
  25. Pachulec E, Neitzke Montinelli V, Viola J. NFAT2 Regulates Generation of Innate-Like CD8+ T Lymphocytes and CD8+ T Lymphocytes Responses. Front Immunol. 2016;7:411 pubmed
  26. Li S, Yang B, Teguh D, Zhou L, Xu J, Rong L. Amyloid ? Peptide Enhances RANKL-Induced Osteoclast Activation through NF-?B, ERK, and Calcium Oscillation Signaling. Int J Mol Sci. 2016;17: pubmed
  27. Liu W, Zhou L, Zhou C, Zhang S, Jing J, Xie L, et al. GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun. 2016;7:12794 pubmed publisher
  28. Shang W, Zhao L, Dong X, Zhao Z, Li J, Zhang B, et al. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Mol Med Rep. 2016;14:3620-6 pubmed publisher
  29. Amara S, Alotaibi D, Tiriveedhi V. NFAT5/STAT3 interaction mediates synergism of high salt with IL-17 towards induction of VEGF-A expression in breast cancer cells. Oncol Lett. 2016;12:933-943 pubmed
  30. Fujiwara T, Zhou J, Ye S, Zhao H. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival. Cell Death Dis. 2016;7:e2300 pubmed publisher
  31. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  32. Klein Hessling S, Rudolf R, Muhammad K, Knobeloch K, Maqbool M, Cauchy P, et al. A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development. Nat Commun. 2016;7:11841 pubmed publisher
  33. Fajardo V, Smith I, Bombardier E, Chambers P, Quadrilatero J, Tupling A. Diaphragm assessment in mice overexpressing phospholamban in slow-twitch type I muscle fibers. Brain Behav. 2016;6:e00470 pubmed publisher
  34. Chen C, Lee C, Liu F, Chen T, Ahmed Ali A, Chang D, et al. Design, synthesis and SARs of novel salicylanilides as potent inhibitors of RANKL-induced osteoclastogenesis and bone resorption. Eur J Med Chem. 2016;117:70-84 pubmed publisher
  35. Huang Y, Chen S, Liu R, Chen Y, Lin C, Huang C, et al. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis. J Mol Med (Berl). 2016;94:1025-37 pubmed publisher
  36. Park S, Yun Y, Lim J, Kim M, Kim S, Kim J, et al. Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration. Nat Commun. 2016;7:10871 pubmed publisher
  37. Munger S, Geng X, Srinivasan R, Witte M, Paul D, Simon A. Segregated Foxc2, NFATc1 and Connexin expression at normal developing venous valves, and Connexin-specific differences in the valve phenotypes of Cx37, Cx43, and Cx47 knockout mice. Dev Biol. 2016;412:173-90 pubmed publisher
  38. Shin J, Nunomiya A, Kitajima Y, Dan T, Miyata T, Nagatomi R. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway. Skelet Muscle. 2016;6:5 pubmed publisher
  39. Monaghan M, Linneweh M, Liebscher S, Van Handel B, Layland S, Schenke Layland K. Endocardial-to-mesenchymal transformation and mesenchymal cell colonization at the onset of human cardiac valve development. Development. 2016;143:473-82 pubmed publisher
  40. Shen W, Taylor B, Jin Q, Nguyen Tran V, Meeusen S, Zhang Y, et al. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation. Nat Commun. 2015;6:8372 pubmed publisher
  41. Lucena P, Faget D, Pachulec E, Robaina M, Klumb C, Robbs B, et al. NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains. Mol Cell Biol. 2016;36:119-31 pubmed publisher
  42. Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, et al. BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival. Cell Death Differ. 2016;23:358-68 pubmed publisher
  43. Hajibeigi A, Dioum E, Guo J, Öz O. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter in response to serum deprivation. Biochem Biophys Res Commun. 2015;465:414-420 pubmed publisher
  44. Gurt I, Artsi H, Cohen Kfir E, Hamdani G, Ben Shalom G, Feinstein B, et al. The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells. PLoS ONE. 2015;10:e0134391 pubmed publisher
  45. Zou Q, Jin J, Xiao Y, Hu H, Zhou X, Jie Z, et al. T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi. J Exp Med. 2015;212:1323-36 pubmed publisher
  46. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7:754-69 pubmed publisher
  47. Rafiei S, Tiedemann K, Tabariès S, Siegel P, Komarova S. Peroxiredoxin 4: a novel secreted mediator of cancer induced osteoclastogenesis. Cancer Lett. 2015;361:262-70 pubmed publisher
  48. Serrano Pérez M, Fernández M, Neria F, Berjón Otero M, Doncel Pérez E, Cano E, et al. NFAT transcription factors regulate survival, proliferation, migration, and differentiation of neural precursor cells. Glia. 2015;63:987-1004 pubmed publisher
  49. Quang C, Leboucher S, Passaro D, Fuhrmann L, Nourieh M, Vincent Salomon A, et al. The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells. Cell Death Dis. 2015;6:e1658 pubmed publisher
  50. Yost E, Hynes T, Hartle C, Ott B, Berlot C. Inhibition of G-protein βγ signaling enhances T cell receptor-stimulated interleukin 2 transcription in CD4+ T helper cells. PLoS ONE. 2015;10:e0116575 pubmed publisher
  51. Zhao X, Zhu L, Chang Q, Jiang C, You Y, Luo T, et al. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation. J Biol Chem. 2014;289:30052-62 pubmed publisher
  52. Lu S, Li M, Lin Y. Mitf regulates osteoclastogenesis by modulating NFATc1 activity. Exp Cell Res. 2014;328:32-43 pubmed publisher
  53. Yu B, Chang J, Liu Y, Li J, Kevork K, Al Hezaimi K, et al. Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-?B. Nat Med. 2014;20:1009-17 pubmed publisher
  54. Baek J, Kim J, Cheon Y, Park S, Ahn S, Yoon K, et al. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone. Molecules. 2014;19:11628-44 pubmed publisher
  55. Tam A, Wadsworth S, Dorscheid D, Man S, Sin D. Estradiol increases mucus synthesis in bronchial epithelial cells. PLoS ONE. 2014;9:e100633 pubmed publisher
  56. Alam M, Gaida M, Ogawa Y, Kolios A, Lasitschka F, Ashwell J. Counter-regulation of T cell effector function by differentially activated p38. J Exp Med. 2014;211:1257-70 pubmed publisher
  57. Yucel G, Altindag B, Gomez Ospina N, Rana A, Panagiotakos G, Lara M, et al. State-dependent signaling by Cav1.2 regulates hair follicle stem cell function. Genes Dev. 2013;27:1217-22 pubmed publisher
  58. Crotti T, Dharmapatni A, Alias E, Zannettino A, Smith M, Haynes D. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. Arthritis Res Ther. 2012;14:R245 pubmed publisher